Autologous peripheral blood stem cell transplantation using Thiotepa, Carboplatin and Etoposide conditioning in patients with relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)
Not Applicable
- Conditions
- relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)
- Registration Number
- JPRN-UMIN000026084
- Lead Sponsor
- agoya University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1 active double cancer 2 active infection needed systemic therapy 3 body temperature more than or equal to 38 degrees C 4 in pregnancy, breastfeeding, strong possibility of pregnancy 5 positive in HBs antigen, HBV-DNA, HCV antibody 6 positive in HIV antibody(no measurement is OK) 7 inadequate for other reason by doctor's assessment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method day100 mortality
- Secondary Outcome Measures
Name Time Method